000 | 01290 a2200337 4500 | ||
---|---|---|---|
005 | 20250516212440.0 | ||
264 | 0 | _c20150928 | |
008 | 201509s 0 0 eng d | ||
022 | _a1464-3405 | ||
024 | 7 |
_a10.1016/j.bmcl.2014.04.043 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRevelant, Germain | |
245 | 0 | 0 |
_aSynthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cJun 2014 |
||
300 |
_a2724-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 |
_aThiadiazoles _xchemical synthesis |
700 | 1 | _aGadais, Charlène | |
700 | 1 | _aMathieu, Véronique | |
700 | 1 | _aKirsch, Gilbert | |
700 | 1 | _aHesse, Stéphanie | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 24 _gno. 12 _gp. 2724-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2014.04.043 _zAvailable from publisher's website |
999 |
_c23813624 _d23813624 |